Randomized Controlled Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 11000-11011
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.11000
Table 3 Results of the main outcome measurement: Crohn’s disease activity index score (per-protocol and intention-to-treat analysis) (mean ± SD)
Analysis setGroupnBaselineChanges from baseline to post-treatmentP value1nChanges from baseline to follow upP value1
PP analysisTreatment43210.84 ± 48.03-115.35 ± 55.05b0.00040-128.93 ± 64.46b0.000
Control42201.04 ± 57.13-35.68 ± 46.91b37-14.32 ± 52.09
ITT analysisTreatment46211.81 ± 50.97-107.83 ± 60.47b0.00046-117.85 ± 70.10b0.000
Control46200.20 ± 54.91-32.58 ± 45.91b46-22.19 ± 55.31b